Tag: Event
-

Best Industry and Not for Profit Collaboration: Finalists
The annual One Nucleus Awards dinner celebrates the excellence of the diverse Life Sciences sector, recognising all parts of the community. One Nucleus believe that it is the interactions and dynamics of the entire ecosystem that lead to successful value and impact creation, the vision that resonates with our team’s. This year, the collaboration between…
-

Back at it again in Boston
This week, Dr Nat Hastings represented innovative research into astrocyte pathology in Parkinson’s at the 14th Alzheimer’s & Parkinson’s Drug Development Summit on behalf of Cellestial Health at Hyatt Regency Boston Harbor. Astrocytic lineage is one of the most populous cell types in the brain, yet the damage Parkinson’s pathology does to it remains underappreciated.…
-

BioSeed 2026: What Matters
On Monday 19th of January, the Cellestial Team attended BioSeed by OBN to re-connect with the London life sciences community and share why our approach to astrocytic network restoration matters in Parkinson’s. ✦ For brain cells, we are looking to reduce the burden of abnormal protein aggregates and inflammation via a novel mechanism✦ For people…
-

Genesis 2025: Current State of Field and De-Risking
The annual Genesis 2025 conference by One Nucleus on Tuesday 3rd of December brought the Life Sciences community together once again, this time under the theme of “𝘔𝘢𝘹𝘪𝘮𝘪𝘴𝘪𝘯𝘨 𝘙𝘦𝘵𝘶𝘳𝘯𝘴 𝘰𝘯 𝘓𝘪𝘧𝘦 𝘚𝘤𝘪𝘦𝘯𝘤𝘦 𝘐𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯”. Dr Nat Hastings delivered a concise presentation on the latest developments at Cellestial Health alongside an array of brilliant companies including LYEONS Neurotech, GutSee Health, and ikarovec; and Martyn Postle actively participated in the networking sessions. The field…
-

BMCS and Parkinson’s UK: New Approaches to the Treatment of Parkinson’s
Dr Nat Hastings represented Cellestial Health at the RSC BMCS and Parkinson’s UK “New Approaches to the Treatment of Parkinson’s” conference on Wednesday 12th, alternating between the corporate exhibitor stand, academic poster presenter, and an audience member of the many insightful talks at the majestic Royal Society of Chemistry halls. Here are the highlights of…
-

One Nucleus #BioWednesday: Ones to Watch in Neuroscience
On Wednesday 22nd of October, a number of select innovative companies presented 5-minute pitches at the One Nucleus BioWednesday evening dedicated to Neuroscience. The opening pitch was delivered by Dr Nat Hastings on behalf of Cellestial Health, discussing our pipeline of small molecule therapeutics designed to protect astrocytic networks and slow down Parkinson’s. A mix…
-

Dazzling Dinner with Cambridge Independent
On Thursday 25th of September Cambridge Independent hosted a Gala dinner to celebrate the 2025 edition of the #CIBusinessAwards at King’s College, Cambridge. The event celebrated a range of local businesses from all sectors, from property management to educational opportunities. It is not easy to stand out in such a diverse environment, and in a…
-

New Chapter for the Kingdom of Saudi Arabia
On October 1-2, King Abdullah International Medical Research Center (KAIMRC) in partnership with J.P. Morgan Asset Management and the Ministry of Investment (MISA) welcomed 10 global finalists startup companies as well as experts from the biotech and pharmaceutical industry in Riyadh at the #LSIF2025, hosted at #KSAUHS Convention Centre.This event supports the goal of SaudiArabia…
-

CRL Science Day: There is No Such Thing as a Model of Parkinson’s
On Wednesday 24th of September Dr Nat Hastings presented at the Charles River Labs Science Day at Chesterford Research Park on a topic that is relevant to Cellestial’s drug development activities and which stirred many discussions – there is no such things as a model of Parkinson’s disease. What does that mean, when many so-called…
-

OBN #BioTuesday: Founders’ Journey
On Tuesday 23rd of September OBN welcomed an audience of life science experts to one of its regular #BioTuesday events, this time kindly hosted by ARC Advanced Research Clusters. The topic of the evening was the Founders’ Journey. The panel discussion chaired by Angela Hobbs invited questions around building a business, hiring, managing finances and…
